The Market Reports

Index

1 Spinal Devices and Biologics Market Overview
1.1 Product Overview and Scope of Spinal Devices and Biologics
1.2 Spinal Devices and Biologics Segment by Type
1.2.1 Global Spinal Devices and Biologics Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Spinal Fusion & Fixation
1.2.3 Motion Preservation
1.2.4 Non-Fusion Technologies
1.2.5 Fracture Treatment
1.2.6 Others
1.3 Spinal Devices and Biologics Segment by Application
1.3.1 Global Spinal Devices and Biologics Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Clinics
1.3.5 Others
1.4 Global Spinal Devices and Biologics Market Size Estimates and Forecasts
1.4.1 Global Spinal Devices and Biologics Revenue 2017-2028
1.4.2 Global Spinal Devices and Biologics Sales 2017-2028
1.4.3 Spinal Devices and Biologics Market Size by Region: 2017 Versus 2021 Versus 2028
2 Spinal Devices and Biologics Market Competition by Manufacturers
2.1 Global Spinal Devices and Biologics Sales Market Share by Manufacturers (2017-2022)
2.2 Global Spinal Devices and Biologics Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Spinal Devices and Biologics Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Spinal Devices and Biologics Manufacturing Sites, Area Served, Product Type
2.5 Spinal Devices and Biologics Market Competitive Situation and Trends
2.5.1 Spinal Devices and Biologics Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Spinal Devices and Biologics Players Market Share by Revenue
2.5.3 Global Spinal Devices and Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Spinal Devices and Biologics Retrospective Market Scenario by Region
3.1 Global Spinal Devices and Biologics Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Spinal Devices and Biologics Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Spinal Devices and Biologics Market Facts & Figures by Country
3.3.1 North America Spinal Devices and Biologics Sales by Country
3.3.2 North America Spinal Devices and Biologics Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Spinal Devices and Biologics Market Facts & Figures by Country
3.4.1 Europe Spinal Devices and Biologics Sales by Country
3.4.2 Europe Spinal Devices and Biologics Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Spinal Devices and Biologics Market Facts & Figures by Region
3.5.1 Asia Pacific Spinal Devices and Biologics Sales by Region
3.5.2 Asia Pacific Spinal Devices and Biologics Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Spinal Devices and Biologics Market Facts & Figures by Country
3.6.1 Latin America Spinal Devices and Biologics Sales by Country
3.6.2 Latin America Spinal Devices and Biologics Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Spinal Devices and Biologics Market Facts & Figures by Country
3.7.1 Middle East and Africa Spinal Devices and Biologics Sales by Country
3.7.2 Middle East and Africa Spinal Devices and Biologics Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Spinal Devices and Biologics Historic Market Analysis by Type
4.1 Global Spinal Devices and Biologics Sales Market Share by Type (2017-2022)
4.2 Global Spinal Devices and Biologics Revenue Market Share by Type (2017-2022)
4.3 Global Spinal Devices and Biologics Price by Type (2017-2022)
5 Global Spinal Devices and Biologics Historic Market Analysis by Application
5.1 Global Spinal Devices and Biologics Sales Market Share by Application (2017-2022)
5.2 Global Spinal Devices and Biologics Revenue Market Share by Application (2017-2022)
5.3 Global Spinal Devices and Biologics Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Nuvasive
6.1.1 Nuvasive Corporation Information
6.1.2 Nuvasive Description and Business Overview
6.1.3 Nuvasive Spinal Devices and Biologics Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Nuvasive Spinal Devices and Biologics Product Portfolio
6.1.5 Nuvasive Recent Developments/Updates
6.2 Orthofix International
6.2.1 Orthofix International Corporation Information
6.2.2 Orthofix International Description and Business Overview
6.2.3 Orthofix International Spinal Devices and Biologics Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Orthofix International Spinal Devices and Biologics Product Portfolio
6.2.5 Orthofix International Recent Developments/Updates
6.3 Exactech
6.3.1 Exactech Corporation Information
6.3.2 Exactech Description and Business Overview
6.3.3 Exactech Spinal Devices and Biologics Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Exactech Spinal Devices and Biologics Product Portfolio
6.3.5 Exactech Recent Developments/Updates
6.4 Wright Medical Group
6.4.1 Wright Medical Group Corporation Information
6.4.2 Wright Medical Group Description and Business Overview
6.4.3 Wright Medical Group Spinal Devices and Biologics Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Wright Medical Group Spinal Devices and Biologics Product Portfolio
6.4.5 Wright Medical Group Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Spinal Devices and Biologics Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Johnson & Johnson Spinal Devices and Biologics Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 Zimmer Biomet
6.6.1 Zimmer Biomet Corporation Information
6.6.2 Zimmer Biomet Description and Business Overview
6.6.3 Zimmer Biomet Spinal Devices and Biologics Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Zimmer Biomet Spinal Devices and Biologics Product Portfolio
6.6.5 Zimmer Biomet Recent Developments/Updates
6.7 Globus Medical
6.6.1 Globus Medical Corporation Information
6.6.2 Globus Medical Description and Business Overview
6.6.3 Globus Medical Spinal Devices and Biologics Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Globus Medical Spinal Devices and Biologics Product Portfolio
6.7.5 Globus Medical Recent Developments/Updates
6.8 K2M
6.8.1 K2M Corporation Information
6.8.2 K2M Description and Business Overview
6.8.3 K2M Spinal Devices and Biologics Sales, Revenue and Gross Margin (2017-2022)
6.8.4 K2M Spinal Devices and Biologics Product Portfolio
6.8.5 K2M Recent Developments/Updates
6.9 Medtronic
6.9.1 Medtronic Corporation Information
6.9.2 Medtronic Description and Business Overview
6.9.3 Medtronic Spinal Devices and Biologics Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Medtronic Spinal Devices and Biologics Product Portfolio
6.9.5 Medtronic Recent Developments/Updates
6.10 Alphatec Holdings
6.10.1 Alphatec Holdings Corporation Information
6.10.2 Alphatec Holdings Description and Business Overview
6.10.3 Alphatec Holdings Spinal Devices and Biologics Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Alphatec Holdings Spinal Devices and Biologics Product Portfolio
6.10.5 Alphatec Holdings Recent Developments/Updates
6.11 RTI Surgical
6.11.1 RTI Surgical Corporation Information
6.11.2 RTI Surgical Spinal Devices and Biologics Description and Business Overview
6.11.3 RTI Surgical Spinal Devices and Biologics Sales, Revenue and Gross Margin (2017-2022)
6.11.4 RTI Surgical Spinal Devices and Biologics Product Portfolio
6.11.5 RTI Surgical Recent Developments/Updates
7 Spinal Devices and Biologics Manufacturing Cost Analysis
7.1 Spinal Devices and Biologics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Spinal Devices and Biologics
7.4 Spinal Devices and Biologics Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Spinal Devices and Biologics Distributors List
8.3 Spinal Devices and Biologics Customers
9 Spinal Devices and Biologics Market Dynamics
9.1 Spinal Devices and Biologics Industry Trends
9.2 Spinal Devices and Biologics Market Drivers
9.3 Spinal Devices and Biologics Market Challenges
9.4 Spinal Devices and Biologics Market Restraints
10 Global Market Forecast
10.1 Spinal Devices and Biologics Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Spinal Devices and Biologics by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Spinal Devices and Biologics by Type (2023-2028)
10.2 Spinal Devices and Biologics Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Spinal Devices and Biologics by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Spinal Devices and Biologics by Application (2023-2028)
10.3 Spinal Devices and Biologics Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Spinal Devices and Biologics by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Spinal Devices and Biologics by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Spinal Devices and Biologics Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Spinal Devices and Biologics Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Spinal Devices and Biologics Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Spinal Devices and Biologics Market Competitive Situation by Manufacturers in 2021
Table 5. Global Spinal Devices and Biologics Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Spinal Devices and Biologics Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Spinal Devices and Biologics Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Spinal Devices and Biologics Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Spinal Devices and Biologics Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Spinal Devices and Biologics Manufacturing Sites and Area Served
Table 11. Manufacturers Spinal Devices and Biologics Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Spinal Devices and Biologics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spinal Devices and Biologics as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Spinal Devices and Biologics Sales by Region (2017-2022) & (K Units)
Table 16. Global Spinal Devices and Biologics Sales Market Share by Region (2017-2022)
Table 17. Global Spinal Devices and Biologics Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Spinal Devices and Biologics Revenue Market Share by Region (2017-2022)
Table 19. North America Spinal Devices and Biologics Sales by Country (2017-2022) & (K Units)
Table 20. North America Spinal Devices and Biologics Sales Market Share by Country (2017-2022)
Table 21. North America Spinal Devices and Biologics Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Spinal Devices and Biologics Revenue Market Share by Country (2017-2022)
Table 23. Europe Spinal Devices and Biologics Sales by Country (2017-2022) & (K Units)
Table 24. Europe Spinal Devices and Biologics Sales Market Share by Country (2017-2022)
Table 25. Europe Spinal Devices and Biologics Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Spinal Devices and Biologics Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Spinal Devices and Biologics Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Spinal Devices and Biologics Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Spinal Devices and Biologics Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Spinal Devices and Biologics Revenue Market Share by Region (2017-2022)
Table 31. Latin America Spinal Devices and Biologics Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Spinal Devices and Biologics Sales Market Share by Country (2017-2022)
Table 33. Latin America Spinal Devices and Biologics Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Spinal Devices and Biologics Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Spinal Devices and Biologics Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Spinal Devices and Biologics Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Spinal Devices and Biologics Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Spinal Devices and Biologics Revenue Market Share by Country (2017-2022)
Table 39. Global Spinal Devices and Biologics Sales by Type (2017-2022) & (K Units)
Table 40. Global Spinal Devices and Biologics Sales Market Share by Type (2017-2022)
Table 41. Global Spinal Devices and Biologics Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Spinal Devices and Biologics Revenue Share by Type (2017-2022)
Table 43. Global Spinal Devices and Biologics Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Spinal Devices and Biologics Sales (K Units) by Application (2017-2022)
Table 45. Global Spinal Devices and Biologics Sales Market Share by Application (2017-2022)
Table 46. Global Spinal Devices and Biologics Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Spinal Devices and Biologics Revenue Share by Application (2017-2022)
Table 48. Global Spinal Devices and Biologics Price by Application (2017-2022) & (USD/Unit)
Table 49. Nuvasive Corporation Information
Table 50. Nuvasive Description and Business Overview
Table 51. Nuvasive Spinal Devices and Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. Nuvasive Spinal Devices and Biologics Product
Table 53. Nuvasive Recent Developments/Updates
Table 54. Orthofix International Corporation Information
Table 55. Orthofix International Description and Business Overview
Table 56. Orthofix International Spinal Devices and Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. Orthofix International Spinal Devices and Biologics Product
Table 58. Orthofix International Recent Developments/Updates
Table 59. Exactech Corporation Information
Table 60. Exactech Description and Business Overview
Table 61. Exactech Spinal Devices and Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Exactech Spinal Devices and Biologics Product
Table 63. Exactech Recent Developments/Updates
Table 64. Wright Medical Group Corporation Information
Table 65. Wright Medical Group Description and Business Overview
Table 66. Wright Medical Group Spinal Devices and Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Wright Medical Group Spinal Devices and Biologics Product
Table 68. Wright Medical Group Recent Developments/Updates
Table 69. Johnson & Johnson Corporation Information
Table 70. Johnson & Johnson Description and Business Overview
Table 71. Johnson & Johnson Spinal Devices and Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Johnson & Johnson Spinal Devices and Biologics Product
Table 73. Johnson & Johnson Recent Developments/Updates
Table 74. Zimmer Biomet Corporation Information
Table 75. Zimmer Biomet Description and Business Overview
Table 76. Zimmer Biomet Spinal Devices and Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Zimmer Biomet Spinal Devices and Biologics Product
Table 78. Zimmer Biomet Recent Developments/Updates
Table 79. Globus Medical Corporation Information
Table 80. Globus Medical Description and Business Overview
Table 81. Globus Medical Spinal Devices and Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Globus Medical Spinal Devices and Biologics Product
Table 83. Globus Medical Recent Developments/Updates
Table 84. K2M Corporation Information
Table 85. K2M Description and Business Overview
Table 86. K2M Spinal Devices and Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. K2M Spinal Devices and Biologics Product
Table 88. K2M Recent Developments/Updates
Table 89. Medtronic Corporation Information
Table 90. Medtronic Description and Business Overview
Table 91. Medtronic Spinal Devices and Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Medtronic Spinal Devices and Biologics Product
Table 93. Medtronic Recent Developments/Updates
Table 94. Alphatec Holdings Corporation Information
Table 95. Alphatec Holdings Description and Business Overview
Table 96. Alphatec Holdings Spinal Devices and Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Alphatec Holdings Spinal Devices and Biologics Product
Table 98. Alphatec Holdings Recent Developments/Updates
Table 99. RTI Surgical Corporation Information
Table 100. RTI Surgical Description and Business Overview
Table 101. RTI Surgical Spinal Devices and Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. RTI Surgical Spinal Devices and Biologics Product
Table 103. RTI Surgical Recent Developments/Updates
Table 104. Production Base and Market Concentration Rate of Raw Material
Table 105. Key Suppliers of Raw Materials
Table 106. Spinal Devices and Biologics Distributors List
Table 107. Spinal Devices and Biologics Customers List
Table 108. Spinal Devices and Biologics Market Trends
Table 109. Spinal Devices and Biologics Market Drivers
Table 110. Spinal Devices and Biologics Market Challenges
Table 111. Spinal Devices and Biologics Market Restraints
Table 112. Global Spinal Devices and Biologics Sales Forecast by Type (2023-2028) & (K Units)
Table 113. Global Spinal Devices and Biologics Sales Market Share Forecast by Type (2023-2028)
Table 114. Global Spinal Devices and Biologics Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 115. Global Spinal Devices and Biologics Revenue Market Share Forecast by Type (2023-2028)
Table 116. Global Spinal Devices and Biologics Sales Forecast by Application (2023-2028) & (K Units)
Table 117. Global Spinal Devices and Biologics Sales Market Share Forecast by Application (2023-2028)
Table 118. Global Spinal Devices and Biologics Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 119. Global Spinal Devices and Biologics Revenue Market Share Forecast by Application (2023-2028)
Table 120. Global Spinal Devices and Biologics Sales Forecast by Region (2023-2028) & (K Units)
Table 121. Global Spinal Devices and Biologics Sales Market Share Forecast by Region (2023-2028)
Table 122. Global Spinal Devices and Biologics Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 123. Global Spinal Devices and Biologics Revenue Market Share Forecast by Region (2023-2028)
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Spinal Devices and Biologics
Figure 2. Global Spinal Devices and Biologics Market Share by Type in 2021 & 2028
Figure 3. Spinal Fusion & Fixation Product Picture
Figure 4. Motion Preservation Product Picture
Figure 5. Non-Fusion Technologies Product Picture
Figure 6. Fracture Treatment Product Picture
Figure 7. Others Product Picture
Figure 8. Global Spinal Devices and Biologics Market Share by Application in 2021 & 2028
Figure 9. Hospitals
Figure 10. Ambulatory Surgical Centers
Figure 11. Clinics
Figure 12. Others
Figure 13. Global Spinal Devices and Biologics Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Spinal Devices and Biologics Market Size (2017-2028) & (US$ Million)
Figure 15. Global Spinal Devices and Biologics Sales (2017-2028) & (K Units)
Figure 16. Spinal Devices and Biologics Sales Share by Manufacturers in 2021
Figure 17. Global Spinal Devices and Biologics Revenue Share by Manufacturers in 2021
Figure 18. The Global 5 and 10 Largest Spinal Devices and Biologics Players: Market Share by Revenue in 2021
Figure 19. Spinal Devices and Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 20. Global Spinal Devices and Biologics Sales Market Share by Region (2017-2022)
Figure 21. Global Spinal Devices and Biologics Sales Market Share by Region in 2021
Figure 22. Global Spinal Devices and Biologics Revenue Market Share by Region (2017-2022)
Figure 23. Global Spinal Devices and Biologics Revenue Market Share by Region in 2021
Figure 24. U.S. Spinal Devices and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Canada Spinal Devices and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Germany Spinal Devices and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. France Spinal Devices and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. U.K. Spinal Devices and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Italy Spinal Devices and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Russia Spinal Devices and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. China Spinal Devices and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Japan Spinal Devices and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. South Korea Spinal Devices and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. India Spinal Devices and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Australia Spinal Devices and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Taiwan Spinal Devices and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Indonesia Spinal Devices and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Thailand Spinal Devices and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Malaysia Spinal Devices and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Philippines Spinal Devices and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Vietnam Spinal Devices and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Mexico Spinal Devices and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Brazil Spinal Devices and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Argentina Spinal Devices and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Turkey Spinal Devices and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Saudi Arabia Spinal Devices and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. U.A.E Spinal Devices and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 48. Sales Market Share of Spinal Devices and Biologics by Type (2017-2022)
Figure 49. Manufacturing Cost Structure of Spinal Devices and Biologics
Figure 50. Manufacturing Process Analysis of Spinal Devices and Biologics
Figure 51. Spinal Devices and Biologics Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed